Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in maxillary sinus augmentation
IRCT2016062527240N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of simvastatin in Alveolar bone atrophy (ABL) and None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Histomorphometric bone formation and Radiographic bone changes. Started Aug 2016; status: completed.
02
Drugs
simvastatin
03
Conditions
Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on IRCT2016062527240N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016062527240N1.